Dr. James John Urbanic, MD

Dr. Urbanic practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Urbanic's NPI, 1164607875, was assigned on January 2, 2008. Dr. Urbanic graduated from Medical University of South Carolina (MUSC) in 2003. Dr. Urbanic's North Carolina license number on file is 2008-00021.

Dr. Urbanic's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Urbanic's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Urbanic is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Urbanic to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Urbanic practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Urbanic's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Urbanic is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Urbanic's licenses on file in 2 states: North Carolina and California.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Urbanic treats.

CMS data shows 1,665 Medicare services from Dr. Urbanic across 18 procedure codes in 2024, for 237 Medicare patients. Medicare paid $180,534 for them.

CMS counts 237 Medicare patients who saw Dr. Urbanic in 2024. The largest group is 65 to 74, with 105 patients. 72% of them have cancer, and 65% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Urbanic's median patient age at 70, with 45% women.

In 2024, Dr. Urbanic wrote 122 Medicare Part D claims for 45 patients. 98% of them were for generic drugs. CMS names the drug for 69 of them, across 4 drugs with 11 or more claims each, at $720 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Urbanic for performance year 2024, reported as part of a group. Dr. Urbanic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Urbanic as offering telehealth.

Dmand AI links 91 papers to Dr. Urbanic, published from 2008 to 2024. 2018 was the busiest year, with 8. The most frequent topics are Lung Neoplasms, Radiosurgery and Radiotherapy Dosage. Dr. Urbanic has published most often in Int J Radiat Oncol Biol Phys. Dr. Urbanic's most frequent co-authors are Jonathan B. Ashman, MD, Steven E. Schild, MD and Henry K. Tsai, MD.

Dmand AI links Dr. Urbanic to 6 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Adrenal Gland Neoplasms, Carcinoma, Non-Small-Cell Lung and Erectile Dysfunction. Wake Forest University Health Sciences sponsors the most, 5.

CMS Open Payments shows 14 general payments to Dr. Urbanic from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,938.

Dmand AI lists 7 awards for Dr. Urbanic, most recently CMS Stage 1 EHR in 2012.

Dr. Urbanic graduated from Medical University of South Carolina (MUSC) in 2003. Dr. Urbanic is a member of ASTRO and ASCO.

Dr. Urbanic is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.